Kemal Yelekçi

2.0k citations

66 papers · 1.6k indexed · 1 hit paper · h-index 22

Molecular Biology top 10%
Organic Chemistry top 5%
Computational Theory and Mathematics top 1%
Pharmacology top 5%
Infectious Diseases top 10%

Co-authors: Ammar D. Elmezayen Abdullahi İbrahim Uba Gülberk Uçar Gamze Bora Hayat Erdem‐Yurter Sevim Dalkara Ayhan S. Demir Didem Dayangaç Erden
Topics: Synthesis and biological activity (18 papers)Histone Deacetylase Inhibitors Research (14 papers)Click Chemistry and Applications (14 papers)
Cited by: Computational Theory and Mathematics Organic Chemistry Pharmacology
Journals: Journal of the American Chemical SocietySHILAP Revista de lepidopterologíaBiochemistry
Partner nations: Türkiye Nigeria United States

In The Last Decade

Kemal Yelekçi

62 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes

2020 288 citations Ammar D. Elmezayen, Kemal Yelekçi et al. Journal of Biomolecular Structure and Dynamics profile →

Peers

Countries citing papers authored by Kemal Yelekçi

Since Specialization

Citations

This map shows the geographic impact of Kemal Yelekçi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kemal Yelekçi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kemal Yelekçi more than expected).

Fields of papers citing papers by Kemal Yelekçi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kemal Yelekçi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kemal Yelekçi. The network helps show where Kemal Yelekçi may publish in the future.

Co-authorship network of co-authors of Kemal Yelekçi

This figure shows the co-authorship network connecting the top 25 collaborators of Kemal Yelekçi. A scholar is included among the top collaborators of Kemal Yelekçi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kemal Yelekçi. Kemal Yelekçi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integrated in vivo and in silico evaluation of antimalarial compounds from Vernonia ambigua leaves identified by GC-MS profiling 2025 ·SHILAP Revista de lepidopterología ·Amina Jega Yusuf,(unknown),(unknown),(unknown),(unknown),Kemal Yelekçi,Abdullahi İbrahim Uba,Mustapha Umar Imam	0
2	Novel azole-urea hybrids as VEGFR-2 inhibitors: Synthesis, in vitro antiproliferative evaluation and in silico studies 2023 ·Journal of Molecular Structure ·(unknown),(unknown),Ömer Erdoğan,Özge Çevik,(unknown),Kemal Yelekçi,Özkan Danış,İlkay Küçükgüzel	8
3	Synthesis and investigation of cytotoxic effects of compounds derived from flurbiprofen 2023 ·Journal of Molecular Structure ·(unknown),(unknown),(unknown),Kemal Yelekçi,Dilek Telci,Ş. Güniz Küçükgüzel	1
4	Novel 1,2,4-triazoles derived from Ibuprofen: synthesis and in vitro evaluation of their mPGES-1 inhibitory and antiproliferative activity 2022 ·Molecular Diversity ·(unknown),Kai Ding,Chang‐Guo Zhan,(unknown),Kemal Yelekçi,(unknown),Özlem Bingöl Özakpınar,(unknown),(unknown),Fikrettin Şahιn,(unknown),(unknown),Mohammad Charehsaz,Esra Tatar,Süheyla Özbey,İlkay Küçükgüzel	6
5	Design, synthesis, molecular modeling, and bioactivity evaluation of 1,10-phenanthroline and prodigiosin (Ps) derivatives and their Copper(I) complexes against mTOR and HDAC enzymes as highly potent and effective new anticancer therapeutic drugs 2022 ·Frontiers in Pharmacology ·M. Mustafa Çetin,Wenjing Peng,Daniel K. Unruh,Michael F. Mayer,Yehia Mechref,Kemal Yelekçi	0
6	Discovery of novel isoform-selective histone deacetylases 5 and 9 inhibitors through combined ligand-based pharmacophore modeling, molecular mocking, and molecular dynamics simulations for cancer treatment 2021 ·Journal of Molecular Graphics and Modelling ·Ammar D. Elmezayen,(unknown),Kemal Yelekçi	2
7	Potential inhibitors of methionine aminopeptidase type II identified via structure-based pharmacophore modeling 2021 ·Molecular Diversity ·(unknown),Abdullahi İbrahim Uba,Kemal Yelekçi	3
8	Homology modeling and in silico design of novel and potential dual-acting inhibitors of human histone deacetylases HDAC5 and HDAC9 isozymes 2020 ·Journal of Biomolecular Structure and Dynamics ·Ammar D. Elmezayen,Kemal Yelekçi	87
9	Synthesis, molecular modeling, in vivo study and anticancer activity against prostate cancer of (+) (S)-naproxen derivatives 2020 ·European Journal of Medicinal Chemistry ·(unknown),Yeliz Yıldırım,H. Yeşim Karasulu,Ercüment Karasulu,Abdullahi İbrahim Uba,Kemal Yelekçi,(unknown),Ahmet Cumaoğlu,Levent Kabasakal,Özgür Yılmaz,Ş. Güniz Küçükgüzel	25
10	Identification of potential inhibitors of human methionine aminopeptidase (type II) for cancer therapy: Structure-based virtual screening, ADMET prediction and molecular dynamics studies 2020 ·Computational Biology and Chemistry ·(unknown),Abdullahi İbrahim Uba,Özlem Keskin,Attila Gürsoy,Kemal Yelekçi	17
11	Crystallographic structure versus homology model: a case study of molecular dynamics simulation of human and zebrafish histone deacetylase 10 2019 ·Journal of Biomolecular Structure and Dynamics ·Abdullahi İbrahim Uba,Kemal Yelekçi	14
12	Pharmacophore-based virtual screening for identification of potential selective inhibitors of human histone deacetylase 6 2018 ·Computational Biology and Chemistry ·Abdullahi İbrahim Uba,Kemal Yelekçi	18
13	Carboxylic acid derivatives display potential selectivity for human histone deacetylase 6: Structure-based virtual screening, molecular docking and dynamics simulation studies 2018 ·Computational Biology and Chemistry ·Abdullahi İbrahim Uba,Kemal Yelekçi	18
14	Corrected Panel-Reactive Antibody Positivity Rates for Hypersensitized Patients in Turkish Population With Calculated Panel-Reactive Antibody Software 2017 ·Transplantation Proceedings ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Kemal Yelekçi,Aydın Türkmen,Ali Aydın,Fatma Savran Oğuz,Mahmut Çarin,Filiz Aydın	0
15	Exploration of the binding pocket of histone deacetylases: the design of potent and isoform-selective inhibitors 2017 ·TURKISH JOURNAL OF BIOLOGY ·Abdullahi İbrahim Uba,Kemal Yelekçi	15
16	Insights into the binding mode of new N-substituted pyrazoline derivatives to MAO-A: docking and quantum chemical calculations 2012 ·Journal of Neural Transmission ·Safiye Sağ Erdem,(unknown),Kemal Yelekçi,Nesrin Gökhan-Kelekçi	7
17	Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors 2009 ·Bioorganic & Medicinal Chemistry ·Nesrin Gökhan-Kelekçi,Ömer Şimşek,Ayşe Ercan,Kemal Yelekçi,Zarife Sibel Şahin,Ş. Işık,Gülberk Uçar,A. Altan Bilgin	33
18	Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies 2009 ·Bioorganic & Medicinal Chemistry ·Gamze Bora,Didem Dayangaç Erden,Ayhan S. Demir,Sevim Dalkara,Kemal Yelekçi,Hayat Erdem‐Yurter	138
19	A computational study on the amine-oxidation mechanism of monoamine oxidase: Insight into the polar nucleophilic mechanism 2006 ·Organic & Biomolecular Chemistry ·Safiye Sağ Erdem,Özlem Karahan,İbrahim Yıldız,Kemal Yelekçi	50
20	Docking studies on monoamine oxidase-B inhibitors: Estimation of inhibition constants (Ki) of a series of experimentally tested compounds 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Kemal Yelekçi	47

About Kemal Yelekçi

Kemal Yelekçi is a scholar working on Organic Chemistry, Pharmacology and Biological Psychiatry, having authored 66 papers that have together received 1.6k indexed citations. Recurring topics across this work include Synthesis and biological activity (18 papers), Histone Deacetylase Inhibitors Research (14 papers) and Click Chemistry and Applications (14 papers). The work is most often cited by research in Computational Theory and Mathematics (471 citations), Organic Chemistry (678 citations) and Pharmacology (270 citations). Kemal Yelekçi has collaborated with scholars based in Türkiye, Nigeria and United States. Frequent co-authors include Ammar D. Elmezayen, Abdullahi İbrahim Uba, Gülberk Uçar, Gamze Bora, Hayat Erdem‐Yurter, Sevim Dalkara, Ayhan S. Demir, Didem Dayangaç Erden, Nesrin Gökhan-Kelekçi and Safiye Sağ Erdem. Their work appears in journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact